Last Updated: May 29, 2023 @ 9:13 am | ||
1001 | Prenatal Panel I | |
Specimen: | Collect: |
|
Submit: |
| |
Special Handling: |
| |
Methodology: |
| |
Performed: | Mon-Fri | |
Reported: | 1-3 Day(s) | |
CPT Codes: |
| |
Interpretive Data: | Please see report for interpretive data. HBsAg INTERPRETIVE NOTES: NEGATIVE: No Evidence of Active (Acute or Chronic) Hepatitis B Virus Infection. POSITIVE: Consistent With Active (Acute or Chronic) Hepatitis B Virus Infection. Patient Is Infective For Hepatitis B. RUBELLA IgG INTERPRETIVE NOTES: NOT IMMUNE: Presumed non-immune to Rubella infection. IMMUNE: Is an indication of previous exposure to the virus either by prior infection or by vaccination. The Rubella IgG cut-off value has been set at 10 IU/mL based on the recommendation of the Clinical and Laboratory Standards Institute subcommittee on Rubella Serology. When the TREPONEMAL AB TOT test is reactive, it will reflex to RPR. If the RPR is non-reactive, it will then reflex to the TREPONEMAL AB IgG test for confirmation. When interpreting these results, consider the patient's history of prior infections and treatment and the patient's risk of re-infection. If diagnosis is still unclear, recommend re-testing in 2-4 weeks. Biotin in specimens taken from patients on high-dose biotin therapy or supplements may intefere with at least one test in this panel and cause inaccurate test results. It is recommended that for patients receiving therapy with high biotin doses (> 5 mg/day), no laboratory test specimen should be taken until at least 8 hours after the last biotin administration. | |
Components: |
|
Disclaimer:
It is preferable to locate tests on the website and not rely on printed test information, which may soon be out of date.
Updated test information can only be guaranteed by using this website.